Viatris Inc (VTRS)
Debt-to-assets ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — |
Total assets | US$ in thousands | 41,500,900 | 47,685,500 | 50,022,200 | 54,842,800 | 61,553,000 |
Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $41,500,900K
= 0.00
Viatris Inc's debt-to-assets ratio has consistently been 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has financed its assets without relying on debt, which may suggest a relatively conservative financial strategy. A low debt-to-assets ratio typically signifies lower financial risk and greater financial stability as the company is not heavily leveraged. Viatris Inc's strong balance sheet in terms of this ratio may be appealing to investors and creditors as it implies a lower probability of default on debt obligations.
Peer comparison
Dec 31, 2024
Company name
Symbol
Debt-to-assets ratio
Viatris Inc
VTRS
0.00
Abbott Laboratories
ABT
0.00
AbbVie Inc
ABBV
0.00
ACADIA Pharmaceuticals Inc
ACAD
0.00
Alkermes Plc
ALKS
0.00
Amphastar P
AMPH
0.39
ANI Pharmaceuticals Inc
ANIP
0.00
Arcus Biosciences Inc
RCUS
0.00
Biomarin Pharmaceutical Inc
BMRN
0.09
Bristol-Myers Squibb Company
BMY
0.51
Catalyst Pharmaceuticals Inc
CPRX
0.00